hif-2α glutathione Targeting HIF-2 Alpha in Renal Cell Carcinoma | Current Treatment Options in Oncology HIF2α: a new therapeutic target
HIF2: a new therapeutic target for NAFLD Nature Reviews Gastroenterology & Hepatology The HIF 2 transcription factor mediates resistance to ferroptosis in pancreatic cancer: Molecular Cell HIF 2 alpha EPAS1 Antibody BSA Free (NB100 122): Novus Biologicals JCI HIF 2 activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20



